P450<sub>BM3</sub>(CYP102A1): connecting the dots 论文

2011Chemical Society Reviews引用 667
Pharmacogenetics and Drug MetabolismEnzyme Catalysis and ImmobilizationComputational Drug Discovery Methods

详细信息

发表期刊/会议
Chemical Society Reviews
发表日期
2011-10-18
发表年份
2011

关键词

Pharmacogenetics and Drug MetabolismEnzyme Catalysis and ImmobilizationComputational Drug Discovery Methods

摘要

P450(BM3) (CYP102A1), a fatty acid hydroxylase from Bacillus megaterium, has been extensively studied over a period of almost forty years. The enzyme has been redesigned to catalyse the oxidation of non-natural substrates as diverse as pharmaceuticals, terpenes and gaseous alkanes using a variety of engineering strategies. Crystal structures have provided a basis for several of the catalytic effects brought about by mutagenesis, while changes to reduction potentials, inter-domain electron transfer rates and catalytic parameters have yielded functional insights. Areas of active research interest include drug metabolite production, the development of process-scale techniques, unravelling general mechanistic aspects of P450 chemistry, methane oxidation, and improving selectivity control to allow the synthesis of fine chemicals. This review draws together the disparate research themes and places them in a historical context with the aim of creating a resource that can be used as a gateway to the field.